We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon
Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
>>Any sense on the timeframe of how long it takes to get BTD after you file for it?<<
My sense is that if the data coming out of the ph II cohort which includes a larger body of CPI-refractory patients warrants it, IMMU will approach the FDA about BTD with that data. Since said data is available and ready to be presented at ESMO, I imagine this conversation has already happened and I believe the FDA will reply to the BTD request within 60-days. Just my sense of things.
"Can anyone imagine what might happen if the biotechs strengthen or good IMMU news breaks out?" So how do the shorts compensate for this ? The Class Action Law Suits start hitting the headlines again. Hang in there newbys, this happens everytime we start seeing positive momentum.
Been trying to gauge what IMMU will present at SABCS this year given TNBC data has already been published, new trials with PARP inhibitors are still too immature to present. What on earth could move mountains?
Hoping this crack(pipe) team can help me dig up info to corroborate my suspicions, but from the looks of it, we have never yet presented OS data on HR+/HER2- patients from the Phase 1/2 data.
Bardia presented data on 54 patients over a year ago at ASCO highlighting PFS & ORR for IMMU-132 in late stage disease, and at that time 70% of patients were still being monitored.
Can someone help confirm that the OS data has never been published, or am I missing something?
All I can find is they aligned with the FDA on final scope for Ph3, but no publishing of OS data.
From the math of it, this number could be a doozy worthy of SABCS presentation...
Results: Fifty-four pts with HR+/HER2- mBC (all female; median age 54 yrs, range 33-79) were accrued between 2/2015 and 6/2017 (has data been published on OS since 6/2017?) ascopubs.org
Take a midpoint of this timeframe, say April 2016, Bardia should have published OS data from this cohort at ASCO theoretically, no?
Keep me on my toes and point out the OS data from this cohort my friends, otherwise, let's see what Santa has in store for us this coming December.
I noticed a 500,095 share transaction at 3:59 for 17.03. This is approximately worth 8.5 million dollars. There was also a 100,000 share transaction at 2:35 and a 113,000 share transaction at 2:34. Would these possibly represent institutional transactions or are those type of transactions kept private? I have also noticed that it is very common that large blocks of shares are often commonly traded at 3:59. Is there some sort of advantage for trading at the last minute? Thanks for any possible explanations.
Probably someone in Idaho doing some high frequency trading to make a few bucks late in the day.
Could be speculators / traders, noting the trading patterns of the past few days, that shows money can be made from the low of the prior day to the high of the next day - not always true for all stocks but easily spotted with an algorithm.
Its important to remember that today, 9.20.19 represents the quarterly "Triple Witching" and "Options Expiration" events. AKA Freaky Friday. This includes Stock market index futures, stock market index options, and regular stock options. Additional volatility is not uncommon.